We are developing macrocycle therapeutics to address “undruggable” targets. Our pipeline is focused in precision oncology.
We are deploying a platform that combines structure-based rational drug design and advanced synthetic chemistry to develop first-in-class macrocycle therapeutics for challenging targets to address unmet clinical needs.
And are looking forward to receiving your application.
